Clinical Trial Detail

NCT ID NCT00990249
Title Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute leukemia

acute lymphoblastic leukemia

lymphoid leukemia

Therapies

anti-thymocyte globulin + Busulfan + Clofarabine

Age Groups: adult

No variant requirements are available.